, Agreement between the European Community and the Swiss Confederation on trade in agricul…

In forcesince 1 Sep 2026
1.

Inspections shall be carried out under the responsibility of the Joint Veterinary Committee in accordance in particular with Article 116 of Regulation (EU) 2017/625 and Article 57 of the Law on epizootic diseases.

2.

Animals traded between the Member States of the European Union and Switzerland shall move under the same conditions as animals traded between the Member States of the European Union. Where necessary, these products are accompanied by the health certificates required for trade between the Member States of the European Union or defined in this Annex and available in the TRACES system.

3.

For the purposes of this Annex, Switzerland is recognised as fulfilling the conditions provided for in Chapter 4 of Part II of Regulation (EU) 2016/429, Commission Delegated Regulation (EU) 2020/689 [Commission Delegated Regulation (EU) 2020/689 of 17 December 2019 supplementing Regulation (EU) 2016/429 of the European Parliament and of the Council as regards rules for surveillance, eradication programmes, and disease-free status for certain listed and emerging diseases (OJ L 174, 3.6.2020, p. 211, ELI: http://data.europa.eu/eli/reg_del/2020/689/oj).] and Commission Implementing Regulation (EU) 2021/620 [Commission Implementing Regulation (EU) 2021/620 of 15 April 2021 laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council as regards the approval of the disease-free and non-vaccination status of certain Member States or zones or compartments thereof as regards certain listed diseases and the approval of eradication programmes for those listed diseases (OJ L 131, 16.4.2021, p. 78, ELI: http://data.europa.eu/eli/reg_impl/2021/620/oj).] as regards the diseases listed in the sites of the Commission ‘Surveillance, eradication programmes and disease-free status – Food Safety’ and of the Federal Food Safety and Veterinary Office ‘National Surveillance Programme’.

For diseases for which Switzerland does not yet have approval of disease-free status, Switzerland shall present to the Joint Veterinary Committee the information required to obtain that status pursuant to Regulation (EU) 2016/429. On the basis of this information, the Joint Veterinary Committee agrees to update the information available on the websites mentioned above.

The Federal Food Safety and Veterinary Office shall immediately notify the Commission of any change in the conditions on which recognition of that status is based for one of the diseases listed in this paragraph. The situation shall be examined within the Joint Veterinary Committee.

4.

For the purposes of this Annex, Switzerland is recognised as fulfilling the conditions laid down in point 1, Section 2, Chapter 3, Part I of Annex IV to Implementing Regulation (EU) 2020/689 as regards bovine tuberculosis. In order to maintain its status as having an officially brucellosis-free bovine herd, Switzerland undertakes to meet the following conditions:

(a)

any animal of the bovine species suspected of being infected with brucellosis shall be reported to the competent authorities and the animal concerned shall undergo the official tests for brucellosis, comprising at least two serological tests with complement fixation and a microbiological examination of suitable samples taken in cases of abortion;

(b)

until such time as suspicion of the disease is lifted, i.e. when the tests provided for in point (a) have produced negative results, the officially brucellosis-free status of the herd to which the animal (or animals) of the bovine species suspected of infection belongs shall be suspended.

5.

Switzerland shall apply the same provisions as those of Article 107 (with the exception of paragraph 6) of Regulation (EU) 2019/6, in conjunction with Article 37(5) thereof on the use of antimicrobial medicinal products in animals intended for production, in accordance with its legislation listed in Section A above.

Switzerland does not authorise either the placing on the market of medicinal products intended for production animals containing one of the antimicrobials or groups of antimicrobials listed in point (2) or (3) of the Annex to Commission Implementing Regulation (EU) 2022/1255 [Commission Implementing Regulation (EU) 2022/1255 of 19 July 2022 designating antimicrobials or groups of antimicrobials reserved for the treatment of certain infections in humans, in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council (OJ L 191, 20.7.2022, p. 58, ELI: http://data.europa.eu/eli/reg_impl/2022/1255/oj).] or the use in production animals of medicinal products for human use containing these antimicrobials or groups of antimicrobials.

Discussions will take place in the Joint Veterinary Committee on amendments to the above-mentioned European Union legislation requiring adaptation of the Swiss provisions.

Therefore, Switzerland shall not be considered as a third country for the purposes of Article 118 of Regulation (EU) 2019/6 until 1 July 2028.

It shall immediately inform the Joint Veterinary Committee of any further changes to its legislation on antimicrobial medicinal products intended for production animals.

This paragraph shall be reviewed by the Joint Veterinary Committee before 1 July 2028.

6.

For consignments of hatching eggs to the European Union, the Swiss authorities undertake to comply with the rules on marking laid down in Commission Regulation (EC) No 617/2008 [Commission Regulation (EC) No 617/2008 of 27 June 2008 laying down detailed rules for implementing Council Regulation (EC) No 1234/2007 as regards marketing standards for eggs for hatching and farmyard poultry chicks (OJ L 168, 28.6.2008, p. 5, ELI: http://data.europa.eu/eli/reg/2008/617/oj).].

7.

In the case of consignments from Switzerland to Finland, Sweden or Denmark, the Swiss authorities undertake to supply the guarantees concerning salmonella required under EU legislation.